The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert on 24 May 2007 about three counterfeit batches of Zyprexa (olanzapine), a neuroleptic (antipsychotic) drug prescribed for schizophrenia, bipolar disorder, and other conditions, made by Eli Lilly
(
Read more... )